167 related articles for article (PubMed ID: 29795142)
1. Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.
Allott EH; Masko EM; Freedland AR; Macias E; Pelton K; Solomon KR; Mostaghel EA; Thomas GV; Pizzo SV; Freeman MR; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):196-203. PubMed ID: 29795142
[TBL] [Abstract][Full Text] [Related]
2. Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.
Masko EM; Alfaqih MA; Solomon KR; Barry WT; Newgard CB; Muehlbauer MJ; Valilis NA; Phillips TE; Poulton SH; Freedland AR; Sun S; Dambal SK; Sanders SE; Macias E; Freeman MR; Dewhirst MW; Pizzo SV; Freedland SJ
Prostate; 2017 Apr; 77(5):446-457. PubMed ID: 27900797
[TBL] [Abstract][Full Text] [Related]
3. Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model.
Allott EH; Macias E; Sanders S; Knudsen BS; Thomas GV; Hursting SD; Freedland SJ
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):165-171. PubMed ID: 28244492
[TBL] [Abstract][Full Text] [Related]
4. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
[TBL] [Abstract][Full Text] [Related]
5. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
[TBL] [Abstract][Full Text] [Related]
6. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
[TBL] [Abstract][Full Text] [Related]
7. Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.
Koike H; Nozawa M; De Velasco MA; Kura Y; Ando N; Fukushima E; Yamamoto Y; Hatanaka Y; Yoshikawa K; Nishio K; Uemura H
Asian Pac J Cancer Prev; 2015; 16(5):1827-31. PubMed ID: 25773832
[TBL] [Abstract][Full Text] [Related]
8. Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.
Ming DS; Pham S; Deb S; Chin MY; Kharmate G; Adomat H; Beheshti EH; Locke J; Guns ET
J Steroid Biochem Mol Biol; 2014 Sep; 143():19-28. PubMed ID: 24565566
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.
Korsten H; Ziel-van der Made AC; van Weerden WM; van der Kwast T; Trapman J; Van Duijn PW
PLoS One; 2016; 11(1):e0147500. PubMed ID: 26807730
[TBL] [Abstract][Full Text] [Related]
10. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma.
Ratnacaram CK; Teletin M; Jiang M; Meng X; Chambon P; Metzger D
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2521-6. PubMed ID: 18268330
[TBL] [Abstract][Full Text] [Related]
11. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
[TBL] [Abstract][Full Text] [Related]
12. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.
Svensson RU; Haverkamp JM; Thedens DR; Cohen MB; Ratliff TL; Henry MD
Am J Pathol; 2011 Jul; 179(1):502-12. PubMed ID: 21703427
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.
Blando JM; Carbajal S; Abel E; Beltran L; Conti C; Fischer S; DiGiovanni J
Neoplasia; 2011 Mar; 13(3):254-65. PubMed ID: 21390188
[TBL] [Abstract][Full Text] [Related]
14. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract][Full Text] [Related]
15. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Narayanan NK; Nargi D; Randolph C; Narayanan BA
Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
[TBL] [Abstract][Full Text] [Related]
16. Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.
Bainor AJ; Deng FM; Wang Y; Lee P; Cantor DJ; Logan SK; David G
Cancer Res; 2017 Oct; 77(19):5339-5348. PubMed ID: 28807943
[TBL] [Abstract][Full Text] [Related]
17. Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
van Duijn PW; Marques RB; Ziel-van der Made ACJ; van Zoggel HJAA; Aghai A; Berrevoets C; Debets R; Jenster G; Trapman J; van Weerden WM
Prostate; 2018 Sep; 78(13):1013-1023. PubMed ID: 30133757
[TBL] [Abstract][Full Text] [Related]
18. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.
Su Q; Zhang B; Zhang L; Dang T; Rowley D; Ittmann M; Xin L
Oncogene; 2017 Feb; 36(5):618-627. PubMed ID: 27345403
[TBL] [Abstract][Full Text] [Related]
19. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
Liao CP; Zhong C; Saribekyan G; Bading J; Park R; Conti PS; Moats R; Berns A; Shi W; Zhou Z; Nikitin AY; Roy-Burman P
Cancer Res; 2007 Aug; 67(15):7525-33. PubMed ID: 17671224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]